Cargando…

Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis

BACKGROUND/AIMS: Fexuprazan is a novel potassium-competitive acid blocker that could be of benefit to patients with gastric mucosal injury. The aim of this study was to assess the 2-week efficacy and safety of fexuprazan in patients with acute or chronic gastritis. METHODS: In this study, 327 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Gwang Ha, Choi, Myung-Gyu, Kim, Jin Il, Lee, Soo Teik, Chun, Hoon Jai, Lee, Kook Lae, Choi, Suk Chei, Jang, Jae-Young, Lee, Yong Chan, Kim, Jae Gyu, Kim, Ki Bae, Shim, Ki-Nam, Sohn, Chong Il, Kim, Sung Kook, Kim, Sang Gyun, Jang, Jin Seok, Kim, Nayoung, Jung, Hwoon-Yong, Park, Hyojin, Huh, Kyu Chan, Lee, Kwang Jae, Hong, Su Jin, Baek, Song, Han, Jin Joo, Lee, Oh Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651377/ https://www.ncbi.nlm.nih.gov/pubmed/36789577 http://dx.doi.org/10.5009/gnl220457

Ejemplares similares

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022)

Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
por: Choi, Yoon Jin, et al.
Publicado: (2017)

The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis
por: Shim, Ki-Nam, et al.
Publicado: (2019)

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects
por: Oh, JungJin, et al.
Publicado: (2023)

Normal Ambulatory 24-Hour Esophageal pH Values in Koreans -A Multicenter Study-
por: Kim, Gwang Ha, et al.
Publicado: (2008)

Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
por: Jeong, Yoo-Seong, et al.
Publicado: (2021)

Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View
por: Cho, Jin Woong, et al.
Publicado: (2014)

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans
por: Kim, Min-Soo, et al.
Publicado: (2022)

A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
por: Park, Su Hyun, et al.
Publicado: (2023)

Cost-effectiveness and short-term clinical outcomes of argon plasma coagulation compared with endoscopic submucosal dissection in the treatment of gastric low-grade dysplasia
por: Kim, Bomin, et al.
Publicado: (2018)

Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
por: Yang, A-Young, et al.
Publicado: (2023)

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension
por: Kim, Young-Il, et al.
Publicado: (2020)

Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016)

Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial
por: Yoon, Hyuk, et al.
Publicado: (2018)

Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015)

Stricture Occurring after Endoscopic Submucosal Dissection for Esophageal and Gastric Tumors
por: Kim, Gwang Ha, et al.
Publicado: (2014)

Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium
por: Lee, Kang Nyeong, et al.
Publicado: (2014)

Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance
por: Kim, Jaedeok, et al.
Publicado: (2022)

The seeded growth of graphene
por: Lee, Jae-Kap, et al.
Publicado: (2014)

Correlations Among Endoscopic, Histologic and Serologic Diagnoses for the Assessment of Atrophic Gastritis
por: Lee, Ju Yup, et al.
Publicado: (2014)

Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection
por: Sung, Jihee, et al.
Publicado: (2018)

Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study
por: Park, Jin Hwa, et al.
Publicado: (2021)

Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
por: Lee, Kwang Jae, et al.
Publicado: (2019)

A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
por: Lee, Oh Young, et al.
Publicado: (2014)

Erratum to: A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
por: Lee, Oh Young, et al.
Publicado: (2014)

Phlegmonous Gastritis with Early Gastric Cancer
por: Kim, Kyung Hee, et al.
Publicado: (2016)

The Nature of Metastable AA’ Graphite: Low Dimensional Nano- and Single-Crystalline Forms
por: Lee, Jae-Kap, et al.
Publicado: (2016)

Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial
por: Cho, Yu Kyung, et al.
Publicado: (2021)

Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis
por: Cho, Yu Kyung, et al.
Publicado: (2022)

Clinical Practice Guideline for Gastritis in Korea
por: Kang, Seung Joo, et al.
Publicado: (2023)

The State of Anesthetic Services in Korea: A National Survey of the Status of Anesthesia Provider in the 2011-2013 Period
por: Kim, Yongsuk, et al.
Publicado: (2016)

Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
por: Choi, Yoon Jin, et al.
Publicado: (2022)

The Impact of Transformational Leadership on Service Employees in the Hotel Industry
por: Kim, Jin-Kyu, et al.
Publicado: (2023)

A Case of Gastritis Associated with Gastric Capillariasis
por: Kim, Jin, et al.
Publicado: (2009)

Influence of midazolam-related genetic polymorphism on conscious sedation during upper gastrointestinal endoscopy in a Korean population
por: Park, Jae Yong, et al.
Publicado: (2019)

Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
por: Kim, Young-Il, et al.
Publicado: (2021)

Essential Oils and Eugenols Inhibit Biofilm Formation and the Virulence of Escherichia coli O157:H7
por: Kim, Yong-Guy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n9j146cvgp3sk7pr8q5jocfvtj